Your browser doesn't support javascript.
loading
The allograft injury marker CXCL9 determines prognosis of anti-HLA antibodies after lung transplantation.
Shino, Michael Y; Zhang, Qiuheng; Li, Ning; Derhovanessian, Ariss; Ramsey, Allison; Saggar, Rajan; Britton, Ian N; Amubieya, Olawale O; Lari, Shahrzad M; Hickey, Michelle; Reed, Elaine F; Noble, Paul W; Stripp, Barry R; Fishbein, Gregory A; Lynch, Joseph P; Ardehali, Abbas; Sayah, David M; Weigt, S Sam; Belperio, John A.
Afiliación
  • Shino MY; Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Zhang Q; Department of Immunogenetics, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Li N; Department of Biomathematics, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Derhovanessian A; Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Ramsey A; Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Saggar R; Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Britton IN; Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Amubieya OO; Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Lari SM; Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Hickey M; Department of Immunogenetics, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Reed EF; Department of Immunogenetics, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Noble PW; Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California, USA.
  • Stripp BR; Department of Medicine, Cedars Sinai Medical Center, Los Angeles, California, USA.
  • Fishbein GA; Department of Pathology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Lynch JP; Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Ardehali A; Division of Cardiothoracic Surgery, Department of Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Sayah DM; Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Weigt SS; Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
  • Belperio JA; Division of Pulmonary and Critical Care Medicine, Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
Am J Transplant ; 22(2): 565-573, 2022 02.
Article en En | MEDLINE | ID: mdl-34464505
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Pulmón / Antígenos HLA Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Am J Transplant Asunto de la revista: TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Pulmón / Antígenos HLA Tipo de estudio: Diagnostic_studies / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Am J Transplant Asunto de la revista: TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos